Skip to main content
Livermore
Livermore
ZHEN

Harding Loevner LP

SEC CIK
0000928196
Latest filing
Aug 14, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Harding Loevner LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
279,294
Value
$70.3M
% of portfolio
0.7%
Quarters held
21
Since Q1 2021
Holdings of ABBV by Harding Loevner LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026279,294$70.3M0.7%−78,522−21.9%ReducedHolders
Q1 2026357,816$77.8M0.8%−13,017−3.5%ReducedHolders
Q4 2025370,833$84.7M0.7%−59,661−13.9%ReducedHolders
Q3 2025430,494$99.7M0.7%−161,894−27.3%ReducedHolders
Q2 2025592,388$110.0M0.7%+9,833+1.7%AddedHolders
Q1 2025582,555$122.1M0.9%−107,767−15.6%ReducedHolders
Q4 2024690,322$122.7M0.8%−140,658−16.9%ReducedHolders
Q3 2024830,980$164.1M0.9%−21,043−2.5%ReducedHolders
Q2 2024852,023$146.1M0.8%−26,217−3.0%ReducedHolders
Q1 2024878,240$159.9M1.0%−76,397−8.0%ReducedHolders
Q4 2023954,637$148.2M0.8%−13,719−1.4%ReducedHolders
Q3 2023968,356$144.3M1.0%+120,463+14.2%AddedHolders
Q2 2023847,893$114.2M0.7%−159,424−15.8%ReducedHolders
Q1 20231,007,317$160.5M0.9%+1,007,317NewHolders
Q4 20220$00.0%−637−100.0%Sold outHolders
Q3 2022637$85.0K<0.1%00.0%UnchangedHolders
Q2 2022637$98.0K<0.1%00.0%UnchangedHolders
Q1 2022637$96.0K<0.1%−210−24.8%ReducedHolders
Q4 2021847$115.0K<0.1%00.0%UnchangedHolders
Q3 2021847$91.0K<0.1%00.0%UnchangedHolders
Q2 2021847$95.0K<0.1%00.0%UnchangedHolders
Q1 2021847$92.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.